Provided by Tiger Trade Technology Pte. Ltd.

KT Corp

17.99
-0.5650-3.05%
Volume:1.39M
Turnover:25.03M
Market Cap:8.56B
PE:9.93
High:18.51
Open:18.51
Low:17.91
Close:18.55
52wk High:24.58
52wk Low:17.13
Shares:476.00M
Float Shares:422.00M
Volume Ratio:1.78
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.81
EPS(LYR):2.46
ROE:7.15%
ROA:2.69%
PB:0.60
PE(LYR):7.30

Loading ...

Korea Exchange Triggered a Market-Wide Circuit Breaker After the KOSPI Fell 8%, Samsung and SK Hynix Each Down 10%

Tiger Newspress
·
Jun 08

KT Corporation Posts Lower Q1 2026 Profit as Auditor Confirms Compliance with Korean IFRS

TIPRANKS
·
May 29

KT SAT Evolves into a 'Total Space Solution Provider' Presenting the Vision of "Space for Humanity"

prnewswire
·
May 22

KT on Track for Lowest Close Since December 2025 -- Data Talk

Dow Jones
·
May 21

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

GlobeNewswire
·
May 15

KT Corp's Q1 Net Profit Plunges 31.5% Amid Data Breach Costs and High Base Effect

Deep News
·
May 13

KT's Net Income Declines 35% in Q1

MT Newswires Live
·
May 12

YKT Corp Sees 1H Net Y25.00M

Dow Jones
·
May 08

Earning Preview: KT Corp this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
May 06

Jasa Kita to Acquire KT System for MYR10 Million; Shares Rally 15%

MT Newswires Live
·
Apr 29

JTEKT Corp FY Net Y11.97B Vs Net Y13.71B

Dow Jones
·
Apr 28

Nomura Adjusts KT's Price Target to KRW62,000 From KRW56,000, Keeps at Neutral

MT Newswires Live
·
Apr 15

KT's 1H Earnings Seen Remaining Weak -- Market Talk

Dow Jones
·
Apr 15

KT Corporation Gains Clean Audit Opinions on 2025 Financials and Internal Controls

TIPRANKS
·
Apr 14

FDA grants fast track designation to Kymera Therapeutics KT-621

TIPRANKS
·
Apr 13

Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate

GlobeNewswire
·
Apr 09